20260511 ESMO Preceptorship on Hereditary Cancer Genetics

ESMO Preceptorship course on hereditary cancer genetics, 11-12 May 2026

The ESMO Preceptorship on Hereditary Cancer Genetics took place on 11-12 May 2026 in Lugano, Switzerland. This preceptorship covered multidisciplinary management, standards of care and future perspectives with the following learning objectives:

• To learn about the best clinical practice in the multidisciplinary management of hereditary cancer syndromes
• To understand the molecular basis and heterogeneity of genetic susceptibility to develop cancer
• To learn how to recognize, diagnose, treat and provide prevention recommendations to patients with a germline genetic susceptibility

The course was attended by 44 participants from 26 countries. The event programme was accredited with 9 ESMO-MORA category 1 points.

For more information, see:

https://www.esmo.org/meeting-calendar/esmo-preceptorship-on-hereditary-cancer-genetics-2026-lugano